Pictured: Joan Massagué
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Friday, July 6, 2012

A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.

Pictured: Harrie Bakst and Duane Bailey-Castro
Event
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, July 5, 2012

More than 2,000 patients and their guests, caregivers, and healthcare providers attended Memorial Sloan Kettering’s cancer survivorship celebrations last month.

Pictured: Farid Boulad
Profile
By Memorial Sloan Kettering  |  Monday, July 2, 2012

Pediatric Day Hospital Medical Director Farid Boulad explains that “we’re trying to excel at caring for the entire child, physically and emotionally.

Pictured: Monica Morrow
Video
By Memorial Sloan Kettering  |  Monday, June 25, 2012

Dr. Morrow, Chief of Memorial Sloan Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.

Pictured: Rhonda D’Agostino
Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, June 18, 2012

Rhonda D’Agostino cares for people with life-threatening complications due to cancer or its treatment – and helped pioneer a new ICU model that trains nurse practitioners and physician assistants to deliver the highest standard of care.

Pictured: Manjit Bains
Video
By Memorial Sloan Kettering  |  Friday, June 15, 2012

Dr. Bains talks about how he and other internationally recognized cancer experts work together to treat patients and help them return to their everyday activities.

New York Magazine's Best Doctors 2012
In the News
By Media Staff  |  Tuesday, June 12, 2012

The magazine’s 15th annual issue recognizes more cancer physicians from Memorial Sloan Kettering than any other hospital.

Pictured: Peter Allen
Video
By Memorial Sloan Kettering  |  Thursday, June 7, 2012

Dr. Allen talks about the specialized team of cancer experts at Memorial Sloan Kettering and the long-term relationships he maintains with his patients.

Feature
By Memorial Sloan Kettering  |  Tuesday, June 5, 2012

Memorial Sloan Kettering and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson to provide medical professionals with improved access to comprehensive cancer data and practices.

Pictured: Chaya Moskowitz
In the Clinic
By Media Staff  |  Monday, June 4, 2012

A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.

Pictured: Howard Scher
Perspective
By Memorial Sloan Kettering  |  Friday, June 1, 2012

Memorial Sloan Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.

Video
By Memorial Sloan Kettering  |  Tuesday, May 29, 2012

Dr. Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.

Pictured: Peter Bach
Q&A
By Allyson Collins, MS, Science Writer/Editor  |  Monday, May 21, 2012

In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.

Pictured: Robert Motzer
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, May 21, 2012

Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.

Pictured: Paul Paik
Finding
By Media Staff  |  Thursday, May 17, 2012

Memorial Sloan Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.

Center News

Stay Informed

Get the latest information about cancer care and research every month.